D.E. Shaw & Co’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-143,707
| Closed | -$2.6M | – | 3288 |
|
|
2024
Q3 | $2.6M | Buy |
+143,707
| New | +$2.6M | ﹤0.01% | 1654 |
|
|
2024
Q2 | – | Sell |
-64,138
| Closed | -$681K | – | 3412 |
|
|
2024
Q1 | $681K | Sell |
64,138
-65,251
| -50% | -$693K | ﹤0.01% | 2281 |
|
|
2023
Q4 | $1.18M | Sell |
129,389
-1,175
| -0.9% | -$10.7K | ﹤0.01% | 1988 |
|
|
2023
Q3 | $1.35M | Buy |
130,564
+16,871
| +15% | +$175K | ﹤0.01% | 1907 |
|
|
2023
Q2 | $1.63M | Buy |
+113,693
| New | +$1.63M | ﹤0.01% | 1848 |
|
|
2022
Q4 | – | Sell |
-14,477
| Closed | -$160K | – | 3744 |
|
|
2022
Q3 | $160K | Sell |
14,477
-47,781
| -77% | -$528K | ﹤0.01% | 3260 |
|
|
2022
Q2 | $525K | Buy |
+62,258
| New | +$525K | ﹤0.01% | 3017 |
|
|
2020
Q1 | – | Sell |
-7,528
| Closed | -$234K | – | 2816 |
|
|
2019
Q4 | $234K | Buy |
+7,528
| New | +$234K | ﹤0.01% | 2453 |
|